Literature DB >> 7298640

Fibrinogen Petoskey, a dysfibrinogenemia characterized by replacement of Arg-A alpha 16 by a histidyl residue. Evidence for thrombin-catalyzed hydrolysis at a histidyl residue.

D L Higgins, J A Shafer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7298640

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  12 in total

1.  Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).

Authors:  S O Brennan; B Hammonds; P M George
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

2.  Fibrinogen Milano IV (A alpha 16 Arg-->His): characterization of its abnormal interaction with human alpha-thrombin.

Authors:  R De Cristofaro; M Furlan; R Landolfi
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

3.  Nucleotide sequence of cDNA and derived amino acid sequence of human complement component C9.

Authors:  R G DiScipio; M R Gehring; E R Podack; C C Kan; T E Hugli; G H Fey
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

4.  Fibrinogen Stony Brook, a heterozygous A alpha 16Arg----Cys dysfibrinogenemia. Evaluation of diminished platelet aggregation support and of enhanced inhibition of fibrin assembly.

Authors:  D K Galanakis; A Henschen; E I Peerschke; M Kehl
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 5.  Structure and function of human fibrinogen inferred from dysfibrinogens.

Authors:  Michio Matsuda; Teruko Sugo
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors.

Authors:  J Hofsteenge; H Taguchi; S R Stone
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

7.  Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis.

Authors:  R F Ebert; W R Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  Identification of the molecular defect in factor IX Chapel Hill: substitution of histidine for arginine at position 145.

Authors:  C M Noyes; M J Griffith; H R Roberts; R L Lundblad
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Characterization of a membrane protease from rat submaxillary-gland mitochondria that possess thrombin-like activity.

Authors:  M Bharadwaj; D Bharadwaj; R N Hati
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

10.  Catalytically competent human and bovine zeta-thrombin and chimeras generated from unfolded polypeptide chains.

Authors:  S D Lewis; D V Brezniak; J W Fenton; J A Shafer
Journal:  Protein Sci       Date:  1992-08       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.